The approval of Sumitomo Pharma's Amchepry makes it the world's first commercialized medical product derived from iPS cells.

When approved, they will be the world’s first practical medicines containing iPS cells, which can be re-engineered into other ...

KYOTO—Researchers have safely transplanted nerve cells generated from induced pluripotent stem (iPS) cells into the brains of ...

A new therapy is offering hope to Parkinson's patients in Japan. They will soon be able to receive the world's first ...

Japan has cleared two therapies that began with the same lab technique and ended in very different parts of the body. One is placed on the surface of the heart. The other is injected deep into the ...

Medical experts have expressed optimism about the potential of a novel stem cell-based therapy for Parkinson's disease known ...

In this collaboration project, we will create these universal cells from iPS cells, and Vita will use them for cell transplantation therapy in FSHD patients What is a DMF (Drug Master File) A DMF ...

Immune cells derived from human induced pluripotent stem, or iPS, cells that are genetically modified to produce two specific proteins simultaneously can improve the therapeutic effect against solid ...

HOUSTON--(BUSINESS WIRE)--IPS HEART has been awarded Orphan Drug Designation (ODD) by the FDA for GIVI-MPCs based on its unique ability to create new muscle with full length dystrophin in Becker ...